However, based on our knowledge, the prognosis of the motor recovery of stroke survivors continues to be a major puzzle in the fundamental cellular mechanism, especially the changes in serum inflammatory markers (interleukins (IL)) and their interaction with neurotrophic biomolecules (brain-derived neurotrophic factor (BDNF)) of the central nervous system. The gene discussed is BDNF; the disease is Stroke.